Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07730788) titled 'Reflectance Confocal Microscopy Evaluation of Skin Structure of Patients With Atopic Dermatitis Under Nemolizumab' on July 23.

Study Type: Observational

Primary Sponsor: Hopitaux Drome Nord

Condition: Atopic Dermatitis (AD) Atopic Dermatitis (Eczema)

Recruitment Status: Recruiting

Date of First Enrollment: June 11, 2026

Target Sample Size: 15

Countries of Recruitment: France

To know more, visit https://clinicaltrials.gov/study/NCT07730788

Disclaimer: Curated by HT Syndication....